Piedmont Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-12,076
| Closed | -$5.9M | – | 544 |
|
|
2020
Q1 | $5.9M | Buy |
12,076
+595
| +5% | +$291K | 0.23% | 101 |
|
|
2019
Q4 | $4.31M | Buy |
11,481
+8,992
| +361% | +$3.38M | 0.15% | 153 |
|
|
2019
Q3 | $690K | Buy |
2,489
+85
| +4% | +$23.6K | 0.03% | 414 |
|
|
2019
Q2 | $752K | Sell |
2,404
-15,205
| -86% | -$4.76M | 0.03% | 397 |
|
|
2019
Q1 | $7.23M | Buy |
17,609
+7,290
| +71% | +$2.99M | 0.29% | 83 |
|
|
2018
Q4 | $3.85M | Buy |
10,319
+414
| +4% | +$155K | 0.18% | 123 |
|
|
2018
Q3 | $4M | Buy |
9,905
+3,143
| +46% | +$1.27M | 0.17% | 131 |
|
|
2018
Q2 | $2.33M | Sell |
6,762
-8,063
| -54% | -$2.78M | 0.11% | 191 |
|
|
2018
Q1 | $5.11M | Sell |
14,825
-5,113
| -26% | -$1.76M | 0.14% | 183 |
|
|
2017
Q4 | $7.5M | Buy |
19,938
+127
| +0.6% | +$47.7K | 0.15% | 175 |
|
|
2017
Q3 | $8.86M | Buy |
19,811
+3,076
| +18% | +$1.38M | 0.19% | 142 |
|
|
2017
Q2 | $8.22M | Buy |
16,735
+276
| +2% | +$136K | 0.18% | 147 |
|
|
2017
Q1 | $6.38M | Sell |
16,459
-1,057
| -6% | -$410K | 0.13% | 192 |
|
|
2016
Q4 | $6.43M | Buy |
17,516
+347
| +2% | +$127K | 0.13% | 177 |
|
|
2016
Q3 | $6.9M | Sell |
17,169
-451
| -3% | -$181K | 0.15% | 161 |
|
|
2016
Q2 | $6.15M | Buy |
17,620
+28
| +0.2% | +$9.78K | 0.13% | 176 |
|
|
2016
Q1 | $6.34M | Buy |
17,592
+270
| +2% | +$97.3K | 0.13% | 164 |
|
|
2015
Q4 | $9.4M | Buy |
17,322
+152
| +0.9% | +$82.5K | 0.2% | 128 |
|
|
2015
Q3 | $7.99M | Buy |
17,170
+139
| +0.8% | +$64.7K | 0.18% | 140 |
|
|
2015
Q2 | $8.69M | Buy |
+17,031
| New | +$8.69M | 0.18% | 140 |
|